Live Quote · NASDAQLPCNHealthcare· Biotechnology

Lipocine Inc.

$1.48▼ 1.33%($-0.02)
MKT CAP $16.39MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
85
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LPCN research report →

Analyst Price Target
$4.00+170.3% vs. today

Range $4 – $4

Analyst RatingBuy
7 Buy2 Hold0 Sell

Price Chart

-53.02% · this period
$11.26$6.35$1.44Nov 20May 26Nov 20
52-Week Range1% of range
Low
$1.36
Current
$1.48
High
$12.37